Chow EJ - Search Results

1

Adverse events among chronic myelogenous leukemia patients treated with tyrosine kinase inhibitors: a real-world analysis of health plan enrollees.

Chow EJ, Doody DR, Wilkes JJ, Becker LK, Chennupati S, Morin PE, Winestone LE, Henk HJ, Lyman GH. Chow EJ, et al. Leuk Lymphoma. 2021 May;62(5):1203-1210. doi: 10.1080/10428194.2020.1855340. Epub 2020 Dec 7. Leuk Lymphoma. 2021. PMID: 33283555 Free PMC article.

2

Late Mortality After Dexrazoxane Treatment: A Report From the Children's Oncology Group.

Chow EJ, Asselin BL, Schwartz CL, Doody DR, Leisenring WM, Aggarwal S, Baker KS, Bhatia S, Constine LS, Freyer DR, Lipshultz SE, Armenian SH. Chow EJ, et al. J Clin Oncol. 2015 Aug 20;33(24):2639-45. doi: 10.1200/JCO.2014.59.4473. Epub 2015 May 26. J Clin Oncol. 2015. PMID: 26014292 Free PMC article. Clinical Trial.

3

Childhood cancer risk in those with chromosomal and non-chromosomal congenital anomalies in Washington State: 1984-2013.

Norwood MS, Lupo PJ, Chow EJ, Scheurer ME, Plon SE, Danysh HE, Spector LG, Carozza SE, Doody DR, Mueller BA. Norwood MS, et al. Among authors: chow ej. PLoS One. 2017 Jun 8;12(6):e0179006. doi: 10.1371/journal.pone.0179006. eCollection 2017. PLoS One. 2017. PMID: 28594943 Free PMC article.

4

Hospitalization and mortality among pediatric cancer survivors: a population-based study.

Mueller BA, Doody DR, Weiss NS, Chow EJ. Mueller BA, et al. Among authors: chow ej. Cancer Causes Control. 2018 Nov;29(11):1047-1057. doi: 10.1007/s10552-018-1078-0. Epub 2018 Sep 5. Cancer Causes Control. 2018. PMID: 30187228

5

Health Care Cost Associated With Contemporary Chronic Myelogenous Leukemia Therapy Compared With That of Other Hematologic Malignancies.

Wilkes JJ, Lyman GH, Doody DR, Chennupati S, Becker LK, Morin PE, Winestone LE, Henk HJ, Chow EJ. Wilkes JJ, et al. Among authors: chow ej. JCO Oncol Pract. 2021 Mar;17(3):e406-e415. doi: 10.1200/OP.20.00143. Epub 2020 Aug 21. JCO Oncol Pract. 2021. PMID: 32822255 Free PMC article.

6

Feasibility of a behavioral intervention using mobile health applications to reduce cardiovascular risk factors in cancer survivors: a pilot randomized controlled trial.

Chow EJ, Doody DR, Di C, Armenian SH, Baker KS, Bricker JB, Gopal AK, Hagen AM, Ketterl TG, Lee SJ, Reding KW, Schenk JM, Syrjala KL, Taylor SA, Wang G, Neuhouser ML, Mendoza JA. Chow EJ, et al. J Cancer Surviv. 2021 Aug;15(4):554-563. doi: 10.1007/s11764-020-00949-w. Epub 2020 Oct 10. J Cancer Surviv. 2021. PMID: 33037989 Free PMC article. Clinical Trial.

7

Impact of Dependent Coverage Provision of the Affordable Care Act on Insurance Continuity for Adolescents and Young Adults With Cancer.

Winestone LE, Hochman LL, Sharpe JE, Alvarez E, Becker L, Chow EJ, Reiter JG, Ginsberg JP, Silber JH. Winestone LE, et al. Among authors: chow ej. JCO Oncol Pract. 2021 Jun;17(6):e882-e890. doi: 10.1200/OP.20.00330. Epub 2020 Oct 22. JCO Oncol Pract. 2021. PMID: 33090897 Free PMC article.

8

Hospitalization and mortality outcomes in the first 5 years after a childhood cancer diagnosis: a population-based study.

Steineck A, Chow EJ, Doody DR, Mueller BA. Steineck A, et al. Among authors: chow ej. Cancer Causes Control. 2021 Jul;32(7):739-752. doi: 10.1007/s10552-021-01425-1. Epub 2021 Apr 9. Cancer Causes Control. 2021. PMID: 33835282 Free PMC article.

9

Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology Group.

Chow EJ, Aplenc R, Vrooman LM, Doody DR, Huang YV, Aggarwal S, Armenian SH, Baker KS, Bhatia S, Constine LS, Freyer DR, Kopp LM, Leisenring WM, Asselin BL, Schwartz CL, Lipshultz SE. Chow EJ, et al. Cancer. 2022 Feb 15;128(4):788-796. doi: 10.1002/cncr.33974. Epub 2021 Oct 13. Cancer. 2022. PMID: 34644414 Free PMC article. Clinical Trial.

10

Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group.

Lipshultz ER, Chow EJ, Doody DR, Armenian SH, Asselin BL, Baker KS, Bhatia S, Constine LS, Freyer DR, Kopp LM, Schwartz CL, Lipshultz SE, Vrooman LM. Lipshultz ER, et al. Among authors: chow ej. Cancer Epidemiol Biomarkers Prev. 2022 Mar 1;31(3):536-542. doi: 10.1158/1055-9965.EPI-21-0360. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 34810210 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

248 results

Search Page

Filters